These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 9919473)

  • 1. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of homocysteine level lowering therapy and fractures.
    Sawka AM; Ray JG; Yi Q; Josse RG; Lonn E
    Arch Intern Med; 2007 Oct; 167(19):2136-9. PubMed ID: 17954810
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
    Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
    Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statement of homocyst(e)ine and cardiovascular disease.
    Heart and Stroke Foundation of Canada
    Can J Cardiol; 2001 Jul; 17(7):763-6. PubMed ID: 11515496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamins and stroke: the homocysteine hypothesis still in doubt.
    Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
    Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Boers GH
    Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.
    Kok FJ
    Bibl Nutr Dieta; 2001; (55):189-91. PubMed ID: 11125576
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine, folic acid, B vitamins and cardiovascular risk.
    Blacher J; Safar ME
    J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [No scientific evidence supports vitamin B treatment of patients with cardiovascular diseases].
    Ekstedt B; Jansson JH; Boman K
    Lakartidningen; 2006 Nov 8-14; 103(45):3464-6. PubMed ID: 17140177
    [No Abstract]   [Full Text] [Related]  

  • 17. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.